The objective of this work is to compare the three-dimensional structures of 'humanized' and mouse-human chimetic forms of a murine monoclonal antibody elicited against human γ-interferon. It is also to provide structural explanations for the small differences in the affinities and biological interactions of the two molecules for this antigen. Antigen-binding fragments (Fabs) were produced by papain hydrolysis of the antibodies and crystallized with polyethylene glycol (PEG) 8000 by nearly identical microseeding procedures. Their structures were solved by X-ray analyses at 2.9 A resolution, using molecular replacement methods and crystallographic refinement. Comparison of these structures revealed marked similarities in the light (L) chains...
For the prevention of hepatitis B virus (HBV) infection, monoclonal antibodies (mAbs) against the su...
Many antibody crystal structures have been solved. Structural modeling programs have been developed ...
Rituximab, a murine–human chimera, is the first monoclonal antibody (mAb) developed as a therapeutic...
Background: The wide range of antibody specificity and affinity results from the differing shapes an...
The structural and dynamic changes introduced during antibody humanization continue to be a topic op...
C(H)2-domain-deleted CC49 (HuCC49DeltaCH2), a recombinant humanized antibody that recognizes the TAG...
The murine single-chain variable fragment F8 (scFv(F8)) is endowed with high intrinsic thermodynamic...
Three single-chain antibody fragments that recognize the extracellular human interferon γ receptor α...
The antibody is the main weapon in the body's defence against invading foreign materials. The differ...
<div><p>A series of mini-antibodies (monovalent and bivalent Fabs) targeting the conserved internal ...
Many antibody crystal structures have been solved. Structural modeling programs have been developed ...
An IgM(κ) immunoglobulin from a patient (Pot) with Waldenstrom's macroglobulinemia was hydrolyzed wi...
Two humanized monoclonal antibody constructs bearing the same variable regions of an anti-CD3 monocl...
Antibodies link antigen and immunological effector systems through the use of highly flexible linker...
The three-dimensional structure of the human histocompatibility antigen HLA-A2 was determined at 3.5...
For the prevention of hepatitis B virus (HBV) infection, monoclonal antibodies (mAbs) against the su...
Many antibody crystal structures have been solved. Structural modeling programs have been developed ...
Rituximab, a murine–human chimera, is the first monoclonal antibody (mAb) developed as a therapeutic...
Background: The wide range of antibody specificity and affinity results from the differing shapes an...
The structural and dynamic changes introduced during antibody humanization continue to be a topic op...
C(H)2-domain-deleted CC49 (HuCC49DeltaCH2), a recombinant humanized antibody that recognizes the TAG...
The murine single-chain variable fragment F8 (scFv(F8)) is endowed with high intrinsic thermodynamic...
Three single-chain antibody fragments that recognize the extracellular human interferon γ receptor α...
The antibody is the main weapon in the body's defence against invading foreign materials. The differ...
<div><p>A series of mini-antibodies (monovalent and bivalent Fabs) targeting the conserved internal ...
Many antibody crystal structures have been solved. Structural modeling programs have been developed ...
An IgM(κ) immunoglobulin from a patient (Pot) with Waldenstrom's macroglobulinemia was hydrolyzed wi...
Two humanized monoclonal antibody constructs bearing the same variable regions of an anti-CD3 monocl...
Antibodies link antigen and immunological effector systems through the use of highly flexible linker...
The three-dimensional structure of the human histocompatibility antigen HLA-A2 was determined at 3.5...
For the prevention of hepatitis B virus (HBV) infection, monoclonal antibodies (mAbs) against the su...
Many antibody crystal structures have been solved. Structural modeling programs have been developed ...
Rituximab, a murine–human chimera, is the first monoclonal antibody (mAb) developed as a therapeutic...